Clinical trials / NCT07446998
NCT07446998Phase 2Active not recruiting

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Study sponsor: Veru Inc. · VERU

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2027-10Estimated
Enrollment · participants239Actual
Source updated2026-09-04Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 3 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

200 participants (planned)

+ After

239 participants (actual)

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source

· 1 field changed

Recruitment status changed

− Before

Not yet recruiting

+ After

Recruiting

Check registry source